These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3965147)

  • 1. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Schmid FA; Otter GM; Mehta BM
    Cancer Res; 1985 Jan; 45(1):40-4. PubMed ID: 3965147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Schmid FA; Otter GM; Chen CF
    Cancer Res; 1986 Sep; 46(9):4469-71. PubMed ID: 3731103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agents.
    Wheeler GP; Adamson DJ; Webster J
    Cancer Res; 1985 Jul; 45(7):3400-2. PubMed ID: 4005864
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
    Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
    Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
    Macquet JP; Cros S; Armand JP
    Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic activity of nitrosourea antitumor agents.
    Franza BR; Oeschger NS; Oeschger MP; Schein PS
    J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected genetic toxicity to rodents of the N',N'-dimethyl analogues of MNU and ENU.
    Tinwell H; Paton D; Guttenplan JB; Ashby J
    Environ Mol Mutagen; 1996; 27(3):202-10. PubMed ID: 8625956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y; Saito M; Fukushima H; Takeda Y; Hara T
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells.
    Erikson JM; Tweedie DJ; Ducore JM; Prough RA
    Cancer Res; 1989 Jan; 49(1):127-33. PubMed ID: 2908840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of spontaneous chemical transformation of arylsulfonylhydrazones of 2-pyridinecarboxaldehyde 1-oxide to anticancer activity.
    Shiba DA; May JA; Sartorelli AC
    Cancer Res; 1983 May; 43(5):2023-9. PubMed ID: 6831433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds.
    Malaveille C; Brun G; Kolar G; Bartsch H
    Cancer Res; 1982 Apr; 42(4):1446-53. PubMed ID: 7060018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
    Yagi MJ; Bekesi JG
    Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of the bitter melon (Momordica charantia).
    Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
    Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP; Schein PS
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract]   [Full Text] [Related]  

  • 18. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
    Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
    Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemia.
    Laduron C; Coune A; Atassi G; Hildebrand J; Ruysschaert JM; Stryckmans P; Brassinne C
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):419-36. PubMed ID: 6190203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210).
    Canti G; Franco P; Marelli O; Ricci L; Nicolin A
    Cancer Res; 1984 Apr; 44(4):1551-6. PubMed ID: 6231100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.